Celebrex might prevent lung cancer in former smokers - Los Angeles Times
The Cox-2 inhibitor celecoxib, better known under the brand name Celebrex, might be able to prevent lung cancer in former smokers, researchers said Wednesday. Studies in a small group of people suggest that the drug, which is normally used to treat arthritis and some other inflammatory diseases, prevents a proliferation of cells that is normally a precursor of lung cancer, the researchers reported in the journal Cancer Prevention Research. But a great deal more research will be necessary to show that the drug actually prevents the initiation of cancer and then that it prevents deaths, experts said.